Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
6.85
-0.02 (-0.29%)
Oct 27, 2025, 4:00 PM EDT - Market closed
Treace Medical Concepts Revenue
Treace Medical Concepts had revenue of $47.39M in the quarter ending June 30, 2025, with 6.60% growth. This brings the company's revenue in the last twelve months to $213.75M, up 7.67% year-over-year. In the year 2024, Treace Medical Concepts had annual revenue of $209.36M with 11.89% growth.
Revenue (ttm)
$213.75M
Revenue Growth
+7.67%
P/S Ratio
2.01
Revenue / Employee
$448,115
Employees
477
Market Cap
432.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 209.36M | 22.24M | 11.89% |
| Dec 31, 2023 | 187.12M | 45.28M | 31.92% |
| Dec 31, 2022 | 141.84M | 47.42M | 50.22% |
| Dec 31, 2021 | 94.42M | 37.05M | 64.59% |
| Dec 31, 2020 | 57.37M | 17.95M | 45.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
TMCI News
- 4 days ago - Treace to Report Third Quarter 2025 Financial Results on November 6, 2025 - GlobeNewsWire
- 6 weeks ago - Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2025 American Orthopaedic Foot & Ankle Society Annual Meeting - GlobeNewsWire
- 7 weeks ago - Treace Medical Concepts, Inc. (TMCI) Investor Day 2025 Call Transcript - Seeking Alpha
- 2 months ago - Treace Medical Concepts, Inc. (TMCI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Treace Medical Concepts Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025 - GlobeNewsWire
- 4 months ago - Notice to Long-Term Shareholders of Maison Solutions Inc. (NASDAQ: MSS); Napco Security Technologies, Inc. (NASDAQ: NSSC); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NYSE: VIRT): Grabar Law Office is Investigating Claims on Yo - GlobeNewsWire
- 5 months ago - TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm - PRNewsWire